Cargando…
Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes
Activated Cdc42-associated kinase 1 (ACK1), a kind of tyrosine kinase, is considered to be an oncogene in many cancers, and it is likely to become a potential target for cancer treatment. We found that the expression of the ACK1 gene in colon cancer was higher than that in normal tissues adjacent to...
Autores principales: | Kong, Defeng, Li, Guoliang, Yang, Zhenrong, Cheng, Shujun, Zhang, Wen, Feng, Lin, Zhang, Kaitai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772074/ https://www.ncbi.nlm.nih.gov/pubmed/35057760 http://dx.doi.org/10.1186/s12885-021-09165-w |
Ejemplares similares
-
Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells
por: Mahajan, Nupam P., et al.
Publicado: (2018) -
Construction and validation of a chemokine family-based signature for the prediction of prognosis and therapeutic response in colon cancer
por: Zhang, Wen, et al.
Publicado: (2023) -
ACK1/TNK2 Tyrosine Kinase: Molecular Signaling and Evolving Role in Cancers
por: Mahajan, Kiran, et al.
Publicado: (2014) -
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer
por: Wu, Xinyan, et al.
Publicado: (2016) -
Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis
por: Kong, Defeng, et al.
Publicado: (2021)